Nucleate Podcast
by Nucleate
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇬🇧GB · Technology#1975K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.5K to 15K🎙 ~2x weekly·44 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇬🇧100% - Active Followers
Loyal subscribers who consistently listen
1.5K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Not detected.
Recent guests
Recent episodes
Translating Science into Patient Impact with Kendra Rose
Jun 23, 2026
1h 03m 50s
Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio
Jun 4, 2026
1h 06m 15s
From Genomics to Deal-Making: How Science Becomes a Company | Laurence Reid, Biotech Entrepreneur
Mar 24, 2026
1h 36m 22s
Negotiating Intellectual Property, Staying Focused, and Making the Most of Mentors with Michal Preminger, Board Member at MassBio
Mar 10, 2026
1h 07m 32s
How Turbine Accelerates Drug Discovery with AI Simulation | Szabi Nagy, CEO and Co-Founder of Turbine
Feb 24, 2026
56m 40s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/23/26 | healthcare innovationscience+3 | Kendra Rose | BayerJohnson & Johnson+2 | — | Kendra RoseBayer+6 | — | 1h 03m 50s | ||
| 6/4/26 | biotechnologyleadership+3 | Jodie Morrison | Q32 BioCEO Forum | COVID-19 | biotechleadership+5 | — | 1h 06m 15s | ||
| 3/24/26 | biotechgenomics+4 | Laurence Reid | otoferlinDecibel Therapeutics+4 | UK | biotechgenomics+5 | — | 1h 36m 22s | ||
| 3/10/26 | intellectual propertymentorship+3 | Michal Preminger | MassBioKendall Square Association | — | intellectual propertymentorship+5 | — | 1h 07m 32s | ||
| 2/24/26 | drug discoveryAI simulation+3 | Szabi Nagy | Turbine | — | drug discoveryAI+5 | — | 56m 40s | ||
| 2/10/26 | stem cellsinfertility treatment+4 | Merrick SmelaTravis Potter | OvelleGoldman Sachs+1 | — | stem cellsinfertility+5 | — | 50m 17s | ||
| 1/27/26 | TechBio investingventure capital+3 | Claire Smith | SpringTide VCMIT+3 | — | TechBioventure capital+5 | — | 1h 03m 01s | ||
| 12/20/25 | functional precision oncologycancer care+5 | Michael ZeringLucas Pelkmans+1 | Apricot BioUniversity of Zurich | ZurichSwitzerland | canceroncology+5 | — | 1h 23m 00s | ||
| 12/10/25 | drug discoverybiotechnology+3 | Christoph Lengauer | Curie.bioBlueprint Medicines+2 | Austria | drug huntingCurie.bio+3 | — | 1h 12m 42s | ||
| 11/21/25 | biotechnologynational security+3 | Alexander Titus | In Vivo GroupAvidity Biosciences+2 | Bay AreaCuba+3 | biotechnational security+5 | — | 1h 07m 49s | ||
| 11/6/25 | healthcareleadership+4 | Mikael Dolsten | PfizerNovo Nordisk+2 | SwedenLund University | Mikael DolstenPfizer+5 | — | 1h 29m 39s | ||
| 10/23/25 | biotechentrepreneurship+4 | John Maraganore | bivalirudinAngiomax+2 | Chicago | biotechRNA interference+5 | — | 1h 02m 35s |
Showing 12 of 12
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Nucleate Podcast
Peaked at #197 in United Kingdom, currently #197 in United Kingdom.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| United Kingdom | — | #197 | #197 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.